Travere Therapeutics 第二季度财报：为何我再次将其评级下调至“持有” (NASDAQ:TVTX)
· seekingalpha.com
Travere 报告称 Filspari 净产品销售额同比增长，其中也包含了 Tiopronin 系列产品的贡献。了解 TVTX 股票为何被下调至“持有”评级。
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...